These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9069520)
41. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia). Chappell DA J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448 [TBL] [Abstract][Full Text] [Related]
42. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Attman PO; Alaupovic P; Tavella M; Knight-Gibson C Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654 [TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles. Bioletto S; Fontana P; Darioli R; James RW Atherosclerosis; 1998 May; 138(1):207-15. PubMed ID: 9678786 [TBL] [Abstract][Full Text] [Related]
44. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias. Iglesias A; Contreras JA; Martínez-Pardo M; Entrala A; Herrera E; Lasunción MA Clin Chim Acta; 1993 Nov; 221(1-2):73-89. PubMed ID: 8149644 [TBL] [Abstract][Full Text] [Related]
45. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146-->Gln) are inefficiently converted to cholesterol-rich lipoproteins. Mulder M; van der Boom H; de Knijff P; Braam C; van den Maagdenberg A; Leuven JA; Havekes LM Atherosclerosis; 1994 Aug; 108(2):183-92. PubMed ID: 7980718 [TBL] [Abstract][Full Text] [Related]
46. [Plasma HDL subfractions in endogenous hypertriglyceridemia]. Xu M; Liu B; Fan P Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):12-5. PubMed ID: 12205910 [TBL] [Abstract][Full Text] [Related]
47. Effects of feeding fish oil on the properties of lipoproteins isolated from rhesus monkeys consuming an atherogenic diet. Soltys PA; Mazzone T; Wissler RW; Vahed S; Rangnekar V; Lukens J; Vesselinovitch D; Getz GS Atherosclerosis; 1989 Apr; 76(2-3):103-15. PubMed ID: 2730707 [TBL] [Abstract][Full Text] [Related]
48. Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods. Stefanutti C; Julius U Atheroscler Suppl; 2015 May; 18():85-94. PubMed ID: 25936310 [TBL] [Abstract][Full Text] [Related]
49. Hypertriglyceridemic subjects exhibit an accumulation of small dense chylomicron particles in the fasting state. Irawati D; Mamo JC; Soares MJ; Slivkoff-Clark KM; James AP Atherosclerosis; 2015 Nov; 243(1):236-41. PubMed ID: 26407667 [TBL] [Abstract][Full Text] [Related]
50. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia. van Barlingen HH; Kock LA; de Man FH; Erkelens DW; de Bruin TW Atherosclerosis; 1996 Mar; 121(1):75-84. PubMed ID: 8678926 [TBL] [Abstract][Full Text] [Related]
51. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267 [TBL] [Abstract][Full Text] [Related]
52. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771 [TBL] [Abstract][Full Text] [Related]
53. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL. Murdoch SJ; Breckenridge WC Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314 [TBL] [Abstract][Full Text] [Related]
54. Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome. Grunfeld C; Doerrler W; Pang M; Jensen P; Weisgraber KH; Feingold KR J Clin Endocrinol Metab; 1997 Nov; 82(11):3734-40. PubMed ID: 9360533 [TBL] [Abstract][Full Text] [Related]
55. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. Mann CJ; Yen FT; Grant AM; Bihain BE J Clin Invest; 1991 Dec; 88(6):2059-66. PubMed ID: 1752964 [TBL] [Abstract][Full Text] [Related]
56. Apolipoprotein B-48 and B-100 very low density lipoproteins. Comparison in dysbetalipoproteinemia (type III) and familial hypertriglyceridemia (type IV). Tercé F; Milne RW; Weech PK; Davignon J; Marcel YL Arteriosclerosis; 1985; 5(2):201-11. PubMed ID: 3977778 [TBL] [Abstract][Full Text] [Related]
57. Effects of particle size on cell uptake of model triglyceride-rich particles with and without apoprotein E. Granot E; Schwiegelshohn B; Tabas I; Gorecki M; Vogel T; Carpentier YA; Deckelbaum RJ Biochemistry; 1994 Dec; 33(50):15190-7. PubMed ID: 7999779 [TBL] [Abstract][Full Text] [Related]
58. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
59. Comprehensive (apo)lipoprotein profiling in patients with genetic hypertriglyceridemia using LC-MS and NMR spectroscopy. Straat ME; Martinez-Tellez B; Nahon KJ; Janssen LGM; Verhoeven A; van der Zee L; Mulder MT; Kooijman S; Boon MR; van Lennep JER; Cobbaert CM; Giera M; Rensen PCN J Clin Lipidol; 2022; 16(4):472-482. PubMed ID: 35568684 [TBL] [Abstract][Full Text] [Related]
60. The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome. Cardona F; Morcillo S; Gonzalo-Marin M; Tinahones FJ J Clin Endocrinol Metab; 2005 May; 90(5):2972-5. PubMed ID: 15713714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]